This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Lung Nodules: Evaluation and Diagnostic Approaches

Lung Nodules: Evaluation and Diagnostic Approaches

Format

Slide Lecture Series

Time to Complete

45 minutes

Released

December 23, 2019

Expires

December 23, 2020
Add to Queue


Maximum Credits

0.75 / AMA PRA Category 1 CreditsTM

Accredited Provider



This activity is provided by Academy for Continued Healthcare Learning.

Sponsors

This activity is sponsored by Cancer Treatment Centers of America® and ACHL.

Program Description

Clincians require education surrounding lung nodules and need to be updated on new and emerging therapies that will lead to individualized treatment and improved outcomes. As technology improves and new data emerges, recommendations for how and when to follow up with patients with lung nodules continues to evolve. This activity provides a platform to understand the latest guidance.

Intended Audience

This program is designed for primary care providers, oncologists, pulmonologists, physician-trainees, pharmacists, nurses and other allied healthcare professionals who are involved in the identification or care of patients with lung nodules.

Educational Objectives

Upon completion of this activity, participants will be able to:
  • Discuss the various diagnostic and staging procedures for lung nodules
  • Select the appropriate approach and follow-up for high-risk patients with lung nodules

Conflict Of Interest Disclosure Policy

ACHL requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commerical services discussed in an educational presentation and (2) with any commerical cupports of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.

Faculty

Abdul Hamid Alraiyes, MD, FCCP
Assistant Professor
Rosalind Franklin University
Director, Interventional Pulmonology
Cancer Treatment Centers of America
Chicago, IL

Dr. Abdul Hamid Alraiyes discloses the following:
Consultant: Medtronic

Accredited Provider Disclosures

ACHL and CTCA staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Credit

0.75

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and Cancer Treatment Centers of America (CTCA). ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Part II CME Activity

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Lung Nodules: Evaluation and Diagnostic Approaches has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

MOC Part II CME Activity
Anesthesiology
Family Medicine
Physical Medicine and Rehabilitation
Psychiatry and Neurology
Radiology

Disclosure of Unlabeled Use

This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Discussion of Off-Label, Investigational, or Experimental Drug Use: None

Disclaimer

The content for this activity was developed independently. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Instructions

This activity will take approximately 45 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 75% must be achieved on the post-test. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

If you have any questions relating to the accreditation of this activity, please contact:
Michelle Forcier
Senior Program Manager, ACHL
mforcier@achlcme.org

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue